SCHEMBL463261

SCHEMBL463261

ClN1CCC(c2noc(-c3ccccc3)n2)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.68
CASP3 P42574 1/20 0.68
SENP7 Q9BQF6 1/20 0.68
SENP6 Q9GZR1 1/20 0.68
USP7 Q93009 2/20 0.56
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
USP30 Q70CQ3 9/20 0.51
HTT P42858 1/20 0.51
HSD11B1 P28845 1/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.47
NR1H4 Q96RI1 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13135838 0.83 USP7 (0.76) POLBCASP3SENP7SENP6USP7
SCHEMBL2896678 0.82 POLB (0.63) POLBCASP3SENP7SENP6USP7
SCHEMBL3241118 0.82 POLB (0.63) POLBCASP3SENP7SENP6USP7
SCHEMBL14305118 0.81 POLB (1.00) POLBCASP3SENP7SENP6USP7
Hydrochloric Acid SCHEMBL3848471 0.81 POLB (0.62) POLBCASP3SENP7SENP6USP7
SCHEMBL3128709 0.80 POLB (0.74) POLBCASP3SENP7SENP6USP7
SCHEMBL2901525 0.80 POLB (0.60) POLBCASP3SENP7SENP6USP7
SCHEMBL407318 0.79 USP7 (0.74) POLBCASP3SENP7SENP6USP7
Hydrochloric Acid SCHEMBL3828123 0.79 HTR4 (0.59) POLBCASP3SENP7SENP6USP7
Hydrochloric Acid SCHEMBL441062 0.78 USP7 (0.72) POLBCASP3SENP7SENP6USP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065196-A1 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-15 US disclosed
WO-2008011130-A2 AMIDE COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065196-A1 AMIDE COMPOUNDS DGAT2, DGAT1, DLAT POLB 2752/4885CASP3 3645/4885SENP7 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.